Product Name: Human GD2 Antibody (Naxitamab, Research Use)
Catalog Number: NBR-0949
Target Name: GD2
Trade Name: Naxitamab
Antibody Drug Description: Naxitamab is a humanised (IgG1) anti-GD2 (hu3F8) monoclonal antibody was developed by the Memorial Sloan Kettering Cancer Center (with commercial rights licenced to Y-mAbs therapeutics Inc.) for the treatment of neuroblastoma, osteosarcoma and other GD2-positive cancers. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: 
Synonyms: 
Target Description: 
Ensembl: 
Uniprot: